These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24909083)

  • 1. Rational design of the first difluorostatone-based PfSUB1 inhibitors.
    Giovani S; Penzo M; Brogi S; Brindisi M; Gemma S; Novellino E; Savini L; Blackman MJ; Campiani G; Butini S
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3582-6. PubMed ID: 24909083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1.
    Gemma S; Giovani S; Brindisi M; Tripaldi P; Brogi S; Savini L; Fiorini I; Novellino E; Butini S; Campiani G; Penzo M; Blackman MJ
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5317-21. PubMed ID: 22796182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multifunctional serine protease primes the malaria parasite for red blood cell invasion.
    Koussis K; Withers-Martinez C; Yeoh S; Child M; Hackett F; Knuepfer E; Juliano L; Woehlbier U; Bujard H; Blackman MJ
    EMBO J; 2009 Mar; 28(6):725-35. PubMed ID: 19214190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum.
    Arastu-Kapur S; Ponder EL; Fonović UP; Yeoh S; Yuan F; Fonović M; Grainger M; Phillips CI; Powers JC; Bogyo M
    Nat Chem Biol; 2008 Mar; 4(3):203-13. PubMed ID: 18246061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.
    Lidumniece E; Withers-Martinez C; Hackett F; Collins CR; Perrin AJ; Koussis K; Bisson C; Blackman MJ; Jirgensons A
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.
    Withers-Martinez C; Suarez C; Fulle S; Kher S; Penzo M; Ebejer JP; Koussis K; Hackett F; Jirgensons A; Finn P; Blackman MJ
    Int J Parasitol; 2012 May; 42(6):597-612. PubMed ID: 22543039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes.
    Yeoh S; O'Donnell RA; Koussis K; Dluzewski AR; Ansell KH; Osborne SA; Hackett F; Withers-Martinez C; Mitchell GH; Bannister LH; Bryans JS; Kettleborough CA; Blackman MJ
    Cell; 2007 Dec; 131(6):1072-83. PubMed ID: 18083098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.
    Carroll CD; Patel H; Johnson TO; Guo T; Orlowski M; He ZM; Cavallaro CL; Guo J; Oksman A; Gluzman IY; Connelly J; Chelsky D; Goldberg DE; Dolle RE
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2315-20. PubMed ID: 9873534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1.
    Kher SS; Penzo M; Fulle S; Finn PW; Blackman MJ; Jirgensons A
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4486-4489. PubMed ID: 25129616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitors.
    Brogi S; Giovani S; Brindisi M; Gemma S; Novellino E; Campiani G; Blackman MJ; Butini S
    J Mol Graph Model; 2016 Mar; 64():121-130. PubMed ID: 26826801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
    Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC
    J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational reverse-engineering of a spider-venom derived peptide active against Plasmodium falciparum SUB1.
    Bastianelli G; Bouillon A; Nguyen C; Crublet E; Pêtres S; Gorgette O; Le-Nguyen D; Barale JC; Nilges M
    PLoS One; 2011; 6(7):e21812. PubMed ID: 21818266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
    Hidaka K; Kimura T; Ruben AJ; Uemura T; Kamiya M; Kiso A; Okamoto T; Tsuchiya Y; Hayashi Y; Freire E; Kiso Y
    Bioorg Med Chem; 2008 Dec; 16(23):10049-60. PubMed ID: 18952439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentapeptide boronic acid inhibitors of Mycobacterium tuberculosis MycP1 protease.
    Frasinyuk MS; Kwiatkowski S; Wagner JM; Evans TJ; Reed RW; Korotkov KV; Watt DS
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3546-8. PubMed ID: 24915878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of binding to the Plasmodium subtilisin-like protease 1.
    Fulle S; Withers-Martinez C; Blackman MJ; Morris GM; Finn PW
    J Chem Inf Model; 2013 Mar; 53(3):573-83. PubMed ID: 23414065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactions.
    Drinkwater N; Vinh NB; Mistry SN; Bamert RS; Ruggeri C; Holleran JP; Loganathan S; Paiardini A; Charman SA; Powell AK; Avery VM; McGowan S; Scammells PJ
    Eur J Med Chem; 2016 Mar; 110():43-64. PubMed ID: 26807544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.
    Lidumniece E; Withers-Martinez C; Hackett F; Blackman MJ; Jirgensons A
    J Med Chem; 2022 Oct; 65(19):12535-12545. PubMed ID: 36137276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors.
    Mistry SN; Drinkwater N; Ruggeri C; Sivaraman KK; Loganathan S; Fletcher S; Drag M; Paiardini A; Avery VM; Scammells PJ; McGowan S
    J Med Chem; 2014 Nov; 57(21):9168-83. PubMed ID: 25299353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
    PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and characterization of catalytic domain of Plasmodium falciparum subtilisin-like protease 3.
    Alam A; Bhatnagar RK; Chauhan VS
    Mol Biochem Parasitol; 2012 May; 183(1):84-9. PubMed ID: 22285468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.